<DOC>
	<DOCNO>NCT02929667</DOCNO>
	<brief_summary>Sudden unexpected death epilepsy patient ( SUDEP ) devastate outcome patient epilepsy . It rank second stroke among neurological disease year potential life lose . Patho-mechanisms SUDEP remain well understood , however peri-ictal respiratory dysfunction likely play important role many case . Literature support critical role serotonergic system central control ventilation . Serotonin neuron raphe nuclei brainstem sense rise carbon dioxide low pH , thereby stimulate breathe arousal . These response may serve mechanism protect asphyxia , particularly sleep post-ictal state . In mouse model seizure-induced sudden death , pre-treatment selective serotonin reuptake inhibitor ( SSRI ) agents prevents death follow seizure . Hence , investigator hypothesize subset drug resistant epilepsy patient impaired central chemo-responsiveness great degree peri-ictal respiratory depression , therefore high risk SUDEP . The investigator hypothesize fluoxetine improve central chemo-responsiveness therefore reduce peri-ictal respiratory depression .</brief_summary>
	<brief_title>Abnormal Ventilatory Response Carbon Dioxide : Potential Biomarker Seizure Induced Respiratory Depression &amp; Modification SSRI</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>1 . Adult patient age 18 old 2 . Drug resistant epilepsy 3 . Native English speaker adequate fluency English provide inform consent . 4 . Female patient childbearing potential must use acceptable method contraception , willing refrain sexual intercourse study . 1 . Progressive neurological disease . 2 . Clinical diagnosis bipolar disease , panic disorder , psychosis severe depression , PHQ9 score &gt; 20 3 . Patients prior hospitalization relate depression Electroconvulsive therapy . 4 . History suicidal ideation intent past present 5 . Clinical history laboratory evidence hepatic renal insufficiency . 6 . Pregnant lactating woman . 7 . Current heavy alcohol use ( &gt; 14 drink per week men &gt; 7 drink per week woman ) ) know medical disorder relate alcohol use current illicit drug use . 8 . Patients recent use ( &lt; 1 month ) already take fluoxetine selective serotonin reuptake inhibitor ( SSRIs ) . 9 . Concurrent use monoamine oxidase inhibitor , antipsychotic agent , antidepressant agent SSRIs frequent use triptan agent ( &gt; 2/week ) . 10 . History previous allergic reaction adverse effect fluoxetine , hypersensitive reactionanaphylaxis ; laryngeal edema ; hive 11 . History serotonin syndrome . 12 . History uncontrolled pulmonary cardiac illness . 13 . Patients hypercapnic ventilatory response ( HCVR ) slope &gt; /=1.3 14 . Patients know prolong QT interval 15 . Patients family history prolong QT interval 16 . Patients family history sudden cardiac death .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Fluoxetine</keyword>
</DOC>